In breast cancer if these mutations do diminish the binding capability of FOXA1, ER's dependency upon FOXA1 for binding (Hurtado et al., 2011) suggests that these tumors may have evolved to become independent of oestrogen for growth. Here, FOXA1 is linked to breast carcinoma.